Suicide and anxiety in DSM-5

Depression and Anxiety

Volumn 30, Issue 10, 2013, Pages 898-901

  Fawcett, Jan ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; LITHIUM; MOOD STABILIZER; OLANZAPINE; QUETIAPINE;

AGITATION; ANXIETY; ANXIETY DISORDER; ARTICLE; CAUSE OF DEATH; CLINICAL ASSESSMENT; COMORBIDITY; DISEASE SEVERITY; DRUG MEGADOSE; DSM-5; GENERALIZED ANXIETY DISORDER; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; PANIC; PRIORITY JOURNAL; RISK FACTOR; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT;

ANXIETY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; RISK ASSESSMENT; RISK FACTORS; SUICIDE;

EID: 84885631820     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22058     Document Type: Article

References (31)

1. American Foundation for Suicide Prevention. AFSP, Facts and Figures; 2012. Available at: www.asfp.org.
2. The Joint Commission Sentinel Event Alert, Issue 46, November 17, 2010.
3. Baldesssarini RJ, Pompili M, Tondo L,. Suicide in bipolar disorder: risks and management. CNS Spectr 2006; 11 (6): 465-471.
4. Harris EC, Baraclough B,. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry 1997; 170: 205-228.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. American Psychiatric Association; 2000.
6. Isometsa ET, Heikkinen ME, Martunen MJ, et al. The last appointment before suicide: is suicide intent communicated? Am J Psychiatry 1995; 152; 919-922.
7. Busch KA, Fawcett J, Jacobs D,. Clinical correlates of inpatient suicide. J Clin Psychiatry 2003; 64 (1): 14-9.
8. Brown GK, Beck AT, Steer BA, Grisham JR,. Risk factors for suicide in psychiatric outpatients: a 20 year prospective study. J Consult Clin Psychol 2000; 68 (3): 371-377.
9. Fava R, Rush AJ, Alpert JE, et al. What clinical symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry 2006; 51: 823-835.
10. Coryell W, Fiedorowicz JG, Solomon D, Leon AC, Rice JP, Keller MB,. Effects of anxiety on long-term course of depressive disorders. Br J Psychiatry 2012; 200 (3): 210-215.
11. Roy A,. Family history of suicide. Arch Gen Psychiatry 1983; 40 (9): 971-974.
12. Brent D,. What family studies teach us about suicidal behavior; implications for research, treatment, prevention. Eur Psychiatry 2010; 25 (5): 260-263.
13. Swann AC, Dougherty DM, Pazzaglia L, et al. Increased impulsivity associated with severity of suicide attempt history in patients with history of bipolar disorder. Am J Psychiatry 2005; 173 (9): 1680-1687.
14. Linnoilla M, Virkunen M,. Biologic correlates of suicidal risk and aggressive behavior. J Clin Psychopharmacology 1992; 12 (12) Supplement 11: 198-208.
15. Nock M, Hwang I, Sampson N, et al. Cross-national analysis of the association of mental disorders and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS Med 2009; 6 (8): 1-17.
16. Sarchiarpone M, Carli V, Marchetti, et al. Family history of suicidal and personality. Arch Suicide Res 2009; 13: 178-184.
17. Coryell W, Young EA,. Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry 66: 412-417.
18. Khan A, Kahn S, Kolts R,. Suicide rates in clinical trials of SSRIs, other antidepressants and placebo: analysis of FDA reports. Am J Psychiatry 2003; 160 (40): 790-792.
19. Angst F, Stassen HH, Clayton PJ, Angst J,. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68: 167-181.
20. Leon AC, Solomon DA, Li C, et al. Antidepressants and risks of suicide and suicide attempts: a 27-year observational study. J Clin Psychiatry 2011; 72 (5): 580-586.
21. Meltzer HY, Alphs L, Green AI, et al. Clozapine treatment for suicidality in schizophrenia. Arch Gen Psychiatry 2003; 60 (1): 82-91.
22. Baldessarini RJ, Tondo L, Davis P, et al. Decreased risk of suicides and attempts during long-term lithium treatment. Bipolar Disord 2006; 8 (5Pt2): 625-639.
23. Marangell LB, Dennehey EB, Wisniewski SR, et al. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD. J Clin Psychiatry 2008; 69 (6): 916-922.
24. Fawcett J, Scheftner WA, Fogg L, et al. Teme related predictors of suicide in major affective disorder. Am J Psychiatry 1990; 147 (9): 1169-1194.
25. Hall RC, Platt DE, Platt RC,. Suicide risk assessment: a review of risk factors for suicide in 100 outpatients who make severe suicide attempts. Psychosomatics 1999; 40 (1): 18-27.
26. Simon GE, Hunleler E, Fireman B, et al. Risk of suicide attempt and suicide death in patients with bipolar disorder. Bipolar Disord 2007; 9 (5): 626-306.
27. Stordal E, Morken G, Mykietun A, et al. J Affect Disord 2008; 106 (3): 273-278.
28. Pfeiffer PN, Ganoczy D, Ilgen M, et al. Comorbid anxiety as a suicide risk factor among depressed veterans. Depress Anxiety 2009; 26: 752-757.
29. Hirschfeld RM, Weisler RH, Raines SR, et al. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2006; 67 (3): 355-623.
30. McIntyre A, Gendron A, McIntyre A,. Quetiapine adjunct to selective serotonin reuptake inhibitors of venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized placebo-controlled pilot study. Depress Anxiety 2007; 24 (7): 487-494.
31. Baker RW, Tohen M, Fawcett J, et al. Acute manic dysphoric mania: treatment response to Olanzapine vs. placebo. J Clin Psychopharmacol 2003; 23 (2): 132-137.